Crossmark

Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina

Crossref DOI link: https://doi.org/10.1007/s41669-022-00352-4

Published Online: 2022-07-14

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Garay, Osvaldo Ulises

Guiñazú, Gonzalo https://orcid.org/0000-0001-5579-5902
Adamczuk, Yolanda Patricia

Duboscq, Cristina
Funding

Funding for this research was provided by:

Roche International
License Information

Text and Data Mining valid from 2022-07-14

Version of Record valid from 2022-07-14
More Information

Article History

Accepted: 29 June 2022

First Online: 14 July 2022

Declarations

:

: This present study was supported by Roche Diagnostics International Ltd.

: N/A. COAGUCHEK, COBAS and COBAS T are trademarks of Roche.

: All data generated or analyzed during this study are included in this Published Article [And Its Supplementary Information Files].

: Osvaldo Ulises Garay and Gonzalo Guiñazú are employees of Roche Diagnostics. Yolanda Patricia Adamczuk and Cristina Duboscq do not report any conflict of interest.

: N/A

: N/A.

: N/A.

: N/A

: Editorial assistance was provided by Erin Slobodian, BA, of Ashfield MedComms (Macclesfield, UK), an Ashfield Health company, funded by Roche Diagnostics International Ltd, Rotkreuz, Switzerland. Thanks to Daniel Vono, Analía Aimetta and Ludmila Frate for their valuable contributions. Study conception/Design: OUG, GG. Data acquisition: OUG, GG, YPA, CD. Data analysis and/or interpretation: OUG, GG. Manuscript writing and/or revision: OUG, GG, YPA, CD. Final version approval: OUG, GG, YPA, CD.

Document is current

Any future updates will be listed below